Clinical Pharmacokinetics of Tuberculosis treatment

Articles (11 in this collection)

1. Influence of Malnutrition on the Pharmacokinetics of Drugs Used in the Treatment of Poverty-Related Diseases: A Systematic Review

   Authors (first, second and last of 5)

   • Luka Verrest
   • Erica A. Wilthagen
   • Thomas P. C. Dorlo

   • Content type: Systematic Review
   • Open Access
   • Published: 01 June 2021

   • Pages: 1149 - 1169

   

2. Population Pharmacokinetics and Bayesian Dose Adjustment to Advance TDM of Anti-TB Drugs

   Authors (first, second and last of 10)

   • Marieke G. G. Sturkenboom
   • Anne-Grete Märtson
   • Jan-Willem C. Alffenaar

   • Content type: Review Article
   • Open Access
   • Published: 06 March 2021

   • Pages: 685 - 710

   

3. A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis

   Authors (first, second and last of 7)

   • Stijn W. van Beek
   • Rob ter Heine
   • the Isoniazid Precision Dosing Group

   • Content type: Original Research Article
   • Open Access
   • Published: 22 February 2021

   • Pages: 943 - 953

   

4. Supra-therapeutic Linezolid Trough Concentrations in Elderly Patients: A Call for Action?

   Authors (first, second and last of 7)

   • Dario Cattaneo
   • Marta Fusi
   • Emilio Clementi

   • Content type: Original Research Article
   • Published: 12 November 2020

   • Pages: 603 - 609

   

5. Pharmacokinetic Modeling, Simulation, and Development of a Limited Sampling Strategy of Cycloserine in Patients with Multidrug-/Extensively Drug-Resistant Tuberculosis

   Authors (first, second and last of 6)

   • Ruben van der Galiën
   • Natasha van’t Boveneind-Vrubleuskaya
   • Jan-Willem C. Alffenaar

   • Content type: Original Research Article
   • Published: 25 January 2020

   • Pages: 899 - 910

   

6. Clinical Significance of the Plasma Protein Binding of Rifampicin in the Treatment of Tuberculosis Patients

   Authors

   • Roger K. Verbeeck
   • Bonifasius S. Singu
   • Dan Kibuule

   • Content type: Commentary
   • Published: 22 July 2019

   • Pages: 1511 - 1515

7. Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis

   Authors (first, second and last of 6)

   • Ahmed Aliyu Abulfathi
   • Eric H. Decloedt
   • Helmuth Reuter

   • Content type: Review Article
   • Published: 03 May 2019

   • Pages: 1103 - 1129

   

8. Optimal Sampling Strategies for Therapeutic Drug Monitoring of First-Line Tuberculosis Drugs in Patients with Tuberculosis

   Authors (first, second and last of 12)

   • Antonia Morita I. Saktiawati
   • Marcel Harkema
   • Marieke G. G. Sturkenboom

   • Content type: Original Research Article
   • Open Access
   • Published: 17 April 2019

   • Pages: 1445 - 1454

9. Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin

   Authors (first, second and last of 6)

   • Stijn W. van Beek
   • Rob ter Heine
   • Elin M. Svensson

   • Content type: Original Research Article
   • Open Access
   • Published: 23 January 2019

   • Pages: 815 - 826

   

10. A Systematic Review on the Effect of HIV Infection on the Pharmacokinetics of First-Line Tuberculosis Drugs

    Authors (first, second and last of 21)

    • Alper Daskapan
    • Lusiana R. Idrus
    • Jan-Willem C. Alffenaar

    • Content type: Systematic Review
    • Open Access
    • Published: 08 November 2018

    • Pages: 747 - 766

    

11. Evidence-Based Design of Fixed-Dose Combinations: Principles and Application to Pediatric Anti-Tuberculosis Therapy

    Authors (first, second and last of 6)

    • Elin M. Svensson
    • Gunnar Yngman
    • Mats O. Karlsson

    • Content type: Original Research Article
    • Open Access
    • Published: 04 August 2017

    • Pages: 591 - 599